Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Men flock to testosterone meds from Abbott, Lilly
| Are testosterone drugs another hormone-replacement ordeal in the making?
Medical Opinions Some doctors think so, Bloomberg reports. The testosterone products, including AndroGel from Abbott Laboratories ($ABT) and Axiron from Eli Lilly ($LLY), are selling like ice cream on a hot day, and they’re expected to keep growing at that pace.
Assessment But. testosterone therapy has its risks, especially in men whose hormone levels aren’t pathologically low. |
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Share this:
Filed under: Drugs and Pharma | Tagged: AndroGel, Axiron, Of Pharma Marketing, Oysters and Testosterone, Testosterone |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Just what I need
Some androgel on my toast and oysters.
Biff
LikeLike
Big Pharma’s Big Fines
The government has fined drug companies billions of dollars for illegally promoting drugs for unapproved uses.
http://www.propublica.org/special/big-pharmas-big-fines
Here’s a closer look at six of the most recent major fraud fines.
Nancy
LikeLike
More on doctors and drug marketing
http://www.kevinmd.com/blog/2013/09/physician-immune-drug-marketing.html
Are physicians immune?
Ali
LikeLike
Big Data + Big Pharma = Big Money
New disclosures from data broker IMS Health reveal how much pharmaceutical firms will pay to know what your doctor is prescribing.
http://www.propublica.org/article/big-data-big-pharma-big-money?utm_source=et&utm_medium=email&utm_campaign=dailynewsletter
Ann Miller RN MHA
LikeLike
Pharma and Doctors
Drug and Medical Device Companies Shelled Out $7.5 Billion to Docs and Hospitals in 2015
http://www.msn.com/en-us/money/companies/drug-and-medical-device-companies-shelled-out-dollar75-billion-to-docs-and-hospitals-in-2015/ar-AAi8usZ?li=BBnb4R7&ocid=U348DHP
Rohan
LikeLiked by 1 person
66% of Doctors Accept Payments from Pharmaceutical and Device Companies
ProPublica recently published an analysis on doctors taking industry payments from pharmaceutical and device companies. Here are some key findings from the report:
• 66% of physicians nationwide took industry payments in 2014.
• 8 in 10 doctors working at New Jersey hospitals took payments in 2014.
• Less than 3 in 10 Kaiser Permanente doctors took a payment in 2014.
• Vermont had the lowest rate of industry interactions at 19%.
• For-profit hospitals had the highest rate of payments to doctors at 75%.
• Federally owned hospitals had the lowest payment rates at 29%.
Source: ProPublica, June 29, 2016
LikeLike